AbCellera Biologics, Inc. (ABCL)
3.10
+0.16
(+5.44%)
USD |
NASDAQ |
Feb 13, 16:00
3.19
+0.09
(+2.90%)
Pre-Market: 20:00
AbCellera Biologics Market Cap : 927.94M for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Achieve Life Sciences, Inc. | 223.58M |
| Oncolytics Biotech, Inc. | 114.06M |
| Aurinia Pharmaceuticals, Inc. | 1.876B |
| Edesa Biotech, Inc. | 8.500M |
| Lexaria Bioscience Corp. | 15.49M |
Market Cap Related Metrics
| PS Ratio | 26.13 |
| Price to Book Value | 0.9626 |
| Price | 3.10 |
| Earnings Yield | -18.59% |